vs

Regeneron’s COVID-19 antibody ‘cocktail’ therapy enters clinical trials—could be ready for emergency use in the fall

Regeneron Pharmaceuticals Inc. said [June 11 that] it is beginning to test in humans a potential coronavirus drug, the latest ...